Technical Analysis for NPCE - Neuropace, Inc.

Grade Last Price % Change Price Change
F 21.0 -1.13% -0.24
NPCE closed down 1.13 percent on Wednesday, July 28, 2021, on 41 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Aug 12
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical NPCE trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Down 3 Days in a Row Weakness -1.13%
Down 4 Days in a Row Weakness -1.13%
Lower Bollinger Band Touch Weakness -1.13%
Older End-of-Day Signals for NPCE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 15 hours ago
Possible NR7 about 15 hours ago
60 Minute Opening Range Breakout about 18 hours ago
Up 2% about 18 hours ago
60 Minute Opening Range Breakdown about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Neuroscience Epilepsy Neuromodulation Neurotechnology Neurophysiology Seizure Electroencephalography Brain–Computer Interfacing Neuroprosthetics

Is NPCE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.38
52 Week Low 18.24
Average Volume 94,618
200-Day Moving Average 0.00
50-Day Moving Average 23.31
20-Day Moving Average 23.09
10-Day Moving Average 23.03
Average True Range 1.48
ADX 13.47
+DI 14.81
-DI 21.55
Chandelier Exit (Long, 3 ATRs) 20.82
Chandelier Exit (Short, 3 ATRs) 25.15
Upper Bollinger Bands 25.46
Lower Bollinger Band 20.72
Percent B (%b) 0.06
BandWidth 20.51
MACD Line -0.35
MACD Signal Line -0.09
MACD Histogram -0.2642
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.28
Resistance 3 (R3) 22.38 22.07 22.06
Resistance 2 (R2) 22.07 21.74 22.01 21.99
Resistance 1 (R1) 21.53 21.54 21.38 21.43 21.92
Pivot Point 21.22 21.22 21.14 21.16 21.22
Support 1 (S1) 20.68 20.89 20.53 20.58 20.08
Support 2 (S2) 20.37 20.69 20.31 20.01
Support 3 (S3) 19.83 20.37 19.94
Support 4 (S4) 19.73